OSLI Retina

August 2020

Issue link: http://osliretina.healio.com/i/1279094

Contents of this Issue


Page 36 of 59

August 2020 · Vol. 51, No. 8 455 2019;39(1):61-68. https://doi.org/10.1097/IAE.0000000000002253 P MID:30015767 6. Lim LS, Ng WY, Mathur R, et al. Conversion to aflibercept for dia- betic macular edema unresponsive to ranibizumab or bevacizumab. Clin Ophthalmol. 2015;9:1715-1718. https://doi.org/10.2147/OPTH. S81523 PMID:26396494 7. Klein KA, Cleary TS, Reichel E. Effect of intravitreal aflibercept on recalci- trant diabetic macular edema. Int J Retina Vitreous. 2017;3(1):16. https:// doi.org/10.1186/s40942-017-0064-0 PMID:28373914 8. Laiginhas R, Silva MI, Rosas V, et al. Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success. Graefes Arch Clin Exp Ophthalmol. 2018;256(1):83-89. https:// doi.org/10.1007/s00417-017-3836-1 PMID:29082448 9. Mira F, Paulo M, Henriques F, Figueira J. Switch to aflibercept in diabetic macular edema patients unresponsive to previous anti-VEGF therapy. J Ophthalmol. 2017;2017:5632634. https://doi.org/10.1155/2017/56326 34 PMID:28348885 10. Do DV, Nguyen QD, Vitti R, et al. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients With and Without Prior Anti-Vascular Endothelial Growth Factor Treatment Outcomes From The Phase 3 Pro- gram. Ophthalmology. 2016;123(4):850-857. https://doi.org/10.1016/j. ophtha.2015.11.008 PMID:26832658 11. Wells JA, Glassman AR, Ayala AR, et al; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness ran- domized clinical trial. Ophthalmology. 2016;123(6):1351-1359. https:// doi.org/10.1016/j.ophtha.2016.02.022 PMID:26935357 12. Rahimy E, Shahlaee A, Khan MA, et al. Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular ede- ma. Am J Ophthalmol. 2016;164:118-27.e2. https://doi.org/10.1016/j. ajo.2015.12.030 PMID:26748058 13. Demircan A, Alkin Z, Yesilkaya C, Demir G, Kemer B. Comparison of intravitreal aflibercept and ranibizumab following initial treatment with ranibizumab in persistent diabetic macular edema. J Ophthalmol. 2018;2018:4171628. https://doi.org/10.1155/2018/4171628 PMID:29 850202 14. Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y. Enlarge- ment of the foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography. Retina. 2015;35(11):2377- 2383. https://doi.org/10.1097/IAE.0000000000000849 PMID:264573 96 15. Niestrata-Ortiz M, Fichna P, Stankiewicz W, Stopa M. Enlargement of the foveal avascular zone detected by optical coherence tomography an- giography in diabetic children without diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2019;257(4):689-697. https://doi.org/10.1007/ s00417-019-04264-8 PMID:30824996 16. Di G, Weihong Y, Xiao Z, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coher- ence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2016;254(5):873-879. https://doi.org/10.1007/s00417-015-3143- 7 PMID:26344729 17. Ghasemi Falavarjani K, Iafe NA, Hubschman JP, Tsui I, Sadda SR, Sar- raf D. Optical coherence tomography angiography analysis of the fo- veal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. Invest Ophthalmol Vis Sci. 2017;58(1):30-34. https://doi.org/10.1167/iovs.16- 20579 PMID:28114569 18. Conti FF, Song W, Rodrigues EB, Singh RP. Changes in retinal and cho- riocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiogra- phy. Int J Retina Vitreous. 2019;5(1):41. https://doi.org/10.1186/s40942- 019-0192-9 PMID:31867124 19. Busch C, Wakabayashi T, Sato T, et al. Retinal microvasculature and visual acuity after intravitreal aflibercept in diabetic macular edema: an optical co- herence tomography angiography study. Sci Rep. 2019;9(1):1561. https:// doi.org/10.1038/s41598-018-38248-1 PMID:30733512 20. Babiuch AS, Conti TF, Conti FF, et al. Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti- VEGF agents (SWAP-TWO study): 6-month interim analysis. Int J Retina Vitreous. 2019;5(1):17. https://doi.org/10.1186/s40942-019- 0167-x PMID:31367468 21. Sorour OA, Sabrosa AS, Yasin Alibhai A, et al. Optical coherence to- mography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthal- mol. 2019;39(10):2361-2371. https://doi.org/10.1007/s10792-019- 01076-x PMID:31119505 22. Michalska-Małecka K, Heinke Knudsen A. Optical coherence tomog- raphy angiography in patients with diabetic retinopathy treated with anti-VEGF intravitreal injections: case report. Medicine (Baltimore). 2017;96(45):e8379. https://doi.org/10.1097/MD.0000000000008379 PMID:29137019 23. Gonzalez VH, Campbell J, Holekamp NM, et al. Early and long-term re- sponses to anti-vascular endothelial growth factor therapy in diabetic mac- ular edema: Analysis of Protocol I data. Am J Ophthalmol. 2016;172:72- 79. https://doi.org/10.1016/j.ajo.2016.09.012 PMID:27644589 24. Ciloglu E, Dogan NC. Optical coherence tomography angiography find- ings in patients with branch retinal vein occlusion treated with anti-VEGF. Arq Bras Oftalmol. 2020;83(2):120-126. https://doi.org/10.5935/0004- 2749.20200017 PMID: 31778447 25. Campochiaro PA, Wykoff CC, Shapiro H, Rubio RG, Ehrlich JS. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Oph- thalmology. 2014;121(9):1783-1789. https://doi.org/10.1016/j.oph- tha.2014.03.021 PMID:24768239 26. Campochiaro PA, Bhisitkul RB, Shapiro H, Rubio RG. Vascular en- dothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion. Ophthalmology. 2013;120(4):795- 802. https://doi.org/10.1016/j.ophtha.2012.09.032 PMID:23260261 27. Papadopoulou DN, Mendrinos E, Mangioris G, Donati G, Pournaras CJ. Intravitreal ranibizumab may induce retinal arteriolar vasoconstric- tion in patients with neovascular age-related macular degeneration. Oph- thalmology. 2009;116(9):1755-1761. https://doi.org/10.1016/j.oph- tha.2009.03.017 PMID:19560206 28. Hikichi T, Agarie M. Reduced vessel density of the choriocapillaris during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2019;60(4):1088- 1095. https://doi.org/10.1167/iovs.18-24522 PMID:30901385 29. Gill A, Cole ED, Novais EA, et al. Visualization of changes in the foveal avascular zone in both observed and treated diabetic macu- lar edema using optical coherence tomography angiography. Int J Retina Vitreous. 2017;3(1):19. https://doi.org/10.1186/s40942-017- 0074-y PMID:28642823 30. Elnahry AG, Abdel-Kader AA, Raafat KA, Elrakhawy K. Evaluation of changes in macular perfusion detected by optical coherence tomog- raphy angiography following 3 intravitreal monthly bevacizumab injec- tions for diabetic macular edema in the IMPACT study. J Ophthalmol. 2020;2020:5814165. https://doi.org/10.1155/2020/5814165 PMID:32 411431 31. Leng Y, Tam EK, Falavarjani KG, Tsui I. Effect of Age and Myopia on Retinal Microvasculture. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):925-931. https://doi.org/10.3928/23258160-20181203- 03 PMID:30566699 32. Chua J, Chin CWL, Hong J, et al. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiogra- phy. J Hypertens. 2019;37(3):572-580. https://doi.org/10.1097/HJH.00 00000000001916 PMID:30113530 33. Lee WH, Park JH, Won Y, et al. Retinal microvascular change in hyper- tension as measured by optical coherence tomography angiography. Sci Rep. 2019;9(1):156. https://doi.org/10.1038/s41598-018-36474- 1 PMID:30655557 34. Nesper PL, Roberts PK, Onishi AC, et al. Quantifying microvascu- lar abnormalities with increasing severity of diabetic retinopathy us- ing optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2017;58(6):BIO307-BIO315. https://doi.org/10.1167/iovs.17- 21787 PMID:29059262 35. Spaide RF, Fujimoto JG, Waheed NK. Image artifacts in optical coher- ence tomography angiography. Retina. 2015;35(11):2163-2180. https:// doi.org/10.1097/IAE.0000000000000765 PMID:26428607 36. Czakó C, István L, Ecsedy M, et al. The effect of image quality on the reli- ability of OCT angiography measurements in patients with diabetes. Int J Retina Vitreous. 2019;5(46):46. https://doi.org/10.1186/s40942-019- 0197-4 PMID:31709114

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - August 2020